CARDENE SR Drug Patent Profile
✉ Email this page to a colleague
When do Cardene Sr patents expire, and what generic alternatives are available?
Cardene Sr is a drug marketed by Chiesi and is included in one NDA.
The generic ingredient in CARDENE SR is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardene Sr
A generic version of CARDENE SR was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARDENE SR?
- What are the global sales for CARDENE SR?
- What is Average Wholesale Price for CARDENE SR?
Summary for CARDENE SR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 173 |
Clinical Trials: | 8 |
Patent Applications: | 1,573 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CARDENE SR at DailyMed |
![CARDENE SR drug patent expirations Drug patent expirations by year for CARDENE SR](/p/graph/s/t/CARDENE_SR-patent-expirations.png)
Recent Clinical Trials for CARDENE SR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Cincinnati | Phase 2 |
Vanderbilt University Medical Center | Phase 2 |
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
US Patents and Regulatory Information for CARDENE SR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-001 | Feb 21, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-002 | Feb 21, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-003 | Feb 21, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDENE SR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-003 | Feb 21, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-003 | Feb 21, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-001 | Feb 21, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-002 | Feb 21, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARDENE SR
See the table below for patents covering CARDENE SR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 47787 | ⤷ Sign Up | |
Austria | 334902 | ⤷ Sign Up | |
Japan | S5545075 | ⤷ Sign Up | |
Japan | S5084577 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |